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Abstract
Background: Frequent causes of high anion gap metabolic acidosis are well known: ethanol, methanol, and ethylene
glycol intoxication; hyperglycemia; lactic or D-lactic acidosis; and impaired renal function. There are other causes, less
frequent but also important. This report illustrates a rare case of a patient with increased anion gap metabolic acidosis
due to a deficit of the γ-glutamyl cycle that led to 5-oxoproline (acid pyroglutamic) accumulation.
Case presentation: An 82-year-old white woman was admitted to our intensive care unit because of septic shock
caused by right knee methicillin-sensitive Staphylococcus aureus-induced arthritis. She was treated for 10 days with
flucloxacillin and rifampicin and developed metabolic acidosis with high anion gap. Her test results for methanol,
ethanol, ethylene glycol, and acetylsalicylic acid were negative. Her glycemia, lactate level, and renal function were
normal. However, the result of a urinary assay for pyroglutamate was positive. We concluded that the patient had
metabolic acidosis induced by accumulation of 5-oxoproline. We modified her antibiotic treatment, administered
acetylcysteine, and her acidosis resolved.
Conclusions: 5-Oxoprolinuria (pyroglutamic acid accumulation) is a rare, probably underdiagnosed cause of transient
metabolic acidosis with increased anion gap.
Keywords: Metabolic acidosis, Anion gap, Pyroglutamic acid, Sepsis, Antibiotic therapy
Background
Metabolic acidosis is frequent in the intensive care unit
(ICU) and can be divided into elevated or normal anion gap
forms, depending on the levels of unmeasured anions in
serum (Table 1). Frequent causes of elevated anion gap
metabolic acidosis are well known: ethanol, methanol, and
ethylene glycol intoxication; hyperglycemia; lactic or D-lactic
acidosis; and impaired renal function. Other, less frequent
causes are important to identify so that treatment ap-
proaches can be adapted appropriately. In this case report,
we describe another cause of high anion gap metabolic acid-
osis due to 5-oxoproline (acid pyroglutamic) accumulation.
Case presentation
An 82-year-old caucasian woman was admitted to the
emergency room of our hospital with pyrexia (40 °C) and
pain in her right knee and leg. She had a history of intraar-
ticular injection of cortisone in the right knee 3 days
before the admission. Her physical examination revealed
erythema of the right lower limb with edema on palpation.
The medical history of the patient was notable for severe
aortic stenosis (estimated surface 1 cm2) with multiple
episodes of hemodynamic pulmonary edema, for which
the patient had refused any intervention; hypertension;
type 2 diabetes mellitus; and a hiatal hernia. Her chronic
treatment consisted of amlodipine, aspirin, olmesartan,
furosemide, metformin, and omeprazole.
Blood testing conducted while the patient was in the
emergency room showed a C-reactive protein (CRP) level
of 47.5 g/L (normal <1 g/L), a bicarbonate level of 24
mmol/L (normal 22-30 mmol/L), and a hemoglobin level
of 9 g/dl (normal 12–15 g/dl). Analysis of her knee fluid re-
vealed the presence of methicillin-sensitive Staphylococcus
aureus, for which she was treated with intravenous fluclox-
acillin (2 g six times per day), oral rifampicin (600 mg every
day), and intravenous acetaminophen (1 g four times per
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day). Ten days after her admission, she developed encephal-
opathy associated with arterial hypotension at 70/50 mmHg
that did not respond to crystalloid administration. The pa-
tient was transferred to the ICU, and blood gas analysis at
her admission revealed increased anion gap metabolic acid-
osis with no elevated lactate level (pH 7.17, partial pressure
of arterial carbon dioxide [PaCO2] 11.2 mmHg, partial
pressure of arterial oxygen [PaO2] 122 mmHg, lactate 1.22
mmol/L).
Blood work conducted at the patient’s ICU admission
confirmed that she had acidosis. She had a bicarbonate
level of 4 mmol/L, a chloride concentration of 119
mmol/L, a sodium concentration of 145 mmol/L, and a
potassium concentration of 3.6 mmol/L. The calculated
anion gap was high at 22 (normal 8–12). The patient’s
plasma osmolality was 283 mOsm/kg. Common causes
of high anion gap metabolic acidosis, such as lactic acid-
osis, ketoacidosis, ingestion of toxic substances, and
renal failure, were ruled out The patient’s blood glucose
level was 174 mg/dl, and her renal function was normal
(creatinine 0.87 mg/dl, normal 0.5–1.2 mg/dl; plasma
urea 31 mg/dl, normal 17–42 mg/dl). A search for blood
and urine ketones returned negative results, and the test
results for levels of methanol, ethanol, and ethylene gly-
col by headspace gas chromatography and for levels
acetylsalicylic acid with gas chromatography-mass spec-
trometry (GC-MS) were also negative. There was no in-
dication of elevated D-lactate levels. In the context of
treatment with flucloxacillin and acetaminophen, as well
as the presence of severe sepsis, metabolic acidosis
by accumulation of 5-oxoproline (pyroglutamic acid)
was suspected. The diagnosis was confirmed by GC-MS
analysis of urinary pyroglutamate (9789 mmol/mmol
creatinine, normal level <14 mmol/mol creatinine).
The treatment consisted of stopping any medication that
inhibits 5-oxoprolinase and causes glutathione deficiency.
We replaced flucloxacillin with co-trimoxazole, which does
not affect this enzyme. We also stopped the administration
of acetaminophen and gave an infusion of acetylcysteine to
replenish the patient’s glutathione stores.
The patient’s condition evolved favorably, and she was
allowed to leave the ICU 8 days later. A blood gas sam-
ple taken at discharge showed regression of the meta-
bolic acidosis (pH 7.53, PaCO2 21.7 mmHg, PaO2 80.2
mmHg, bicarbonate 18 mmol/L, calculated anion gap 8)
and regression of the inflammatory syndrome (CRP 3.1
g/dl). The result of follow-up analysis of urinary pyroglu-
tamate 15 days later was negative.
Discussion
5-Oxoprolinuria is a rare cause of increased anion gap
metabolic acidosis. Pyroglutamic acid is dissociated in H+
and pyroglutamate. Increase in this unmeasured anion
leads to high-anion-gap metabolic acidosis. This pathology
is due to an anomaly of the γ-glutamyl cycle (Fig. 1) in-
volved in the synthesis and metabolism of glutathione [1].
Glutathione is formed from glutamic acid, cysteine, and
glycine; is a major cellular antioxidant; and is also involved
in the regulation of apoptosis, cell cycling, and immunity.
5-Oxoprolinuria results most often from an enzymatic de-
ficiency at the level of glutathione synthetase (Fig. 1, step
1) or 5-oxoprolinase (Fig. 1, step 4). The first catalyzes the
transformation of γ-glutamylcysteine into glutathione, and
the second catalyzes the conversion of 5-oxoproline (also
called pyroglutamic acid) to L-glutamate [2].
Glutathione synthetase deficiency induces a decrease
in the rate of glutathione production and an increase in
γ-glutamylcysteine levels (Fig. 1, step 1). Glutathione
deficiency produces negative feedback for the γ-
glutamylcysteine synthetase (Fig. 1, step 2) and causes
an increase of γ-glutamylcysteine [3]. As described by
Schurmans et al. [4], this situation occurs more fre-
quently in women (82 % of the cases reported) and
during liver failure, malnutrition, sepsis, and treatment
with certain drugs (including antiepileptic drugs and
acetaminophen) that deplete glutathione [5]. Notable
Table 1 Causes of high and normal anion gap metabolic acidosis
Increased anion gap Normal anion gap
Lactic acidosis Toluene ingestion (if late and if renal function is preserved)
Ketoacidosis: diabetes mellitus, starvation, alcohol use-associated Diarrhea or other intestinal losses
Ingestion: methanol, ethylene glycol, aspirin, toluene (if early or if renal failure),
diethylene glycol, propylene glycol
Type 2 renal tubular acidosis (proximal)
D-lactic acidosis After treatment of ketoacidosis
Massive rhabdomyolysis Carbonic anhydrase inhibitors
Pyroglutamic acidosis Ureteral diversion
Chronic kidney disease Chronic kidney disease and tubular dysfunction (but relatively
preserved glomerular filtration rate)
Type 1 renal tubular acidosis (distal)
Type 4 renal tubular acidosis (hyperaldosteronism)
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symptoms include encephalopathy, neurologic disorders,
seizures, or hemolytic anemia [6].
On the one hand, accumulation of γ-glutamylcysteine is
rare, because it is usually metabolized to 5-oxoproline,
through a secondary pathway, by γ-glutamylcyclotransferase
(Fig. 1, step 3). 5-Oxoproline is subsequently converted
to L-glutamate by 5-oxoprolinase (Fig. 1, step 4). On the
other hand, this enzyme is quickly satured, which can
lead to the accumulation of pyroglutamic acid. This
enzyme can be deficient due to a genetic abnormality
(recessive autosomal) or inhibited by medications such
as flucloxacillin (penicillin), ciprofloxacin (quinolone),
or netilmicin (aminoglycoside) [7].
Our patient was a woman with sepsis who was treated
symptomatically with acetaminophen. This situation prob-
ably led to glutathione deficiency and an increase of γ- glu-
tamylcysteine. In addition, she received flucloxacillin for 10
days, which causes an increase in the rate of 5-oxoproline
by inhibition of 5-oxoprolinase (see Fig. 1, step 4). These
two mechanisms led to anion gap metabolic acidosis. The
diagnosis was confirmed by the presence of increased
urinary concentration of pyroglutamate [5]. In cases of
associated kidney failure with decrease urine output (renal
elimination of the pyroglutamate), a blood measurement
can be performed instead of the standard urinalysis. Treat-
ment consisted of discontinuation of the drugs that caused
the problem. Administration of N-acetylcysteine to replen-
ish stores of glutathione may be considered.
Conclusions
5-Oxoprolinuria (pyroglutamic acid accumulation) is a
rare, probably underdiagnosed cause of metabolic acidosis
with increased anion gap. It is important to keep this
possibility in mind for any patient with unexplained meta-
bolic acidosis whose clinical features combine several risk
factors (female sex, sepsis, malnutrition, liver failure, and
certain medications), because the condition can be fatal
and the treatment is simple. All the medications that can
inhibit enzymes involved in the γ-glutamyl cycle and that
consume glutathione must be discontinued. The adminis-
tration of N-acetylcysteine may be recommended to
replenish stores of glutathione.
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Fig. 1 The γ-glutamyl cycle. Step 1: Glutathione synthetase deficiency induces a decrease in the levels of glutathione and an increase of γ - glutamyl
cysteine. Step 2: Glutathione deficiency induces negative feedback in the γ-glutamyl-cysteine synthetase. Step 3: 5-oxoproline is produced by γ-glutamyl
cyclotransferase from γ-glutamyl-cysteine. Step 4: 5-oxoproline is converted to L-glutamate by the 5-oxoprolinase, which is quickly saturated
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